CAS 749-02-0: Spiperone
Formula:C23H26FN3O2
InChI:InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)
InChI key:InChIKey=DKGZKTPJOSAWFA-UHFFFAOYSA-N
SMILES:O=C1C2(N(CN1)C3=CC=CC=C3)CCN(CCCC(=O)C4=CC=C(F)C=C4)CC2
Synonyms:- 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(3-(p-fluorobenzoyl)propyl)-1-phenyl-
- 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-
- 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one
- 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane
- 8-[3-(4-Fluorobenzoyl)propyl]-4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]decane
- 8-[4-(4-Fluorophenyl)-4-Oxobutyl]-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-4-One
- 8-[4-(4-Fluorophenyl)-4-Oxobutyl]-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-4-One Hydrochloride (1:1)
- Brn 0632204
- Butyrophenone, 4'-fluoro-4-(4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decan-8-yl)-
- E 525
- Espiperona
- See more synonyms
Sort by
Found 7 products.
Spiperone
CAS:Spiperone (Spiropitan) is a spiro butyrophenone analog similar to HALOPERIDOL and other related compounds.Formula:C23H26FN3O2Purity:99.34% - 99.89%Color and Shape:SolidMolecular weight:395.47Spiperone
CAS:Formula:C23H26FN3O2Purity:≥ 95.0%Color and Shape:White to off-white solidMolecular weight:395.47Spiperone
CAS:Controlled ProductApplications Spiperone is an antipsychotic. References Chivers, J., et al.: Br. J. Pharmacol., 90, 467 (1987); Lever, J.R., et al.: Life Sci., 46, 1967 (1990);Formula:C23H26FN3O2Color and Shape:WhiteMolecular weight:395.478-[4-(4-Fluprophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one
CAS:8-[4-(4-Fluprophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one (8OHPPD) is a prodrug that is hydrolyzed in vivo to 8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decane (8FBP), its active form. This drug has been shown to be an effective treatment for bowel disease and eye disorders. It activates the 5HT2C receptor in the brain and this activation may be responsible for its beneficial effects on bowel disease. 8OHPPD also has shown anticancer activity against breast cancer cells that express high levels of HER2+ receptors. The drug inhibits dopamine release by binding to 5HT2 receptors and it has been shown to inhibit tumor growth in mouse models of breast cancerFormula:C23H26FN3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:395.47 g/molRef: 3D-FF27863
Discontinued product
![8-[4-(4-Fluprophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFF27863.jpg&w=3840&q=75)
